328 related articles for article (PubMed ID: 29093579)
1. [Hygiene and legal aspects of occupational exposure assessment to cytostatics].
Kupczewska-Dobecka M; Pałaszewska-Tkacz A; Czerczak S; Konieczko K
Med Pr; 2018 Jan; 69(1):77-92. PubMed ID: 29093579
[TBL] [Abstract][Full Text] [Related]
2. Cytostatics as hazardous chemicals in healthcare workers' environment.
Pałaszewska-Tkacz A; Czerczak S; Konieczko K; Kupczewska-Dobecka M
Int J Occup Med Environ Health; 2019 Apr; 32(2):141-159. PubMed ID: 30896680
[TBL] [Abstract][Full Text] [Related]
3. [Carcinogenic and mutagenic agents in the workplace, Poland, 2011-2012].
Pałaszewska-Tkacz A; Czerczak S; Konieczko K
Med Pr; 2015; 66(1):29-38. PubMed ID: 26016043
[TBL] [Abstract][Full Text] [Related]
4. [Fluorouracil and doxorubicin - cardiotoxic cytostatics in the workplace].
Kupczewska-Dobecka M; Czerczak S
Med Pr; 2020 May; 71(3):363-373. PubMed ID: 32372765
[TBL] [Abstract][Full Text] [Related]
5. [Carcinogenic or mutagenic chemical substances and technological processes in the workplace in Poland in 2013-2017].
Niepsuj A; Czerczak S; Konieczko K
Med Pr; 2020 Mar; 71(2):187-203. PubMed ID: 32225180
[TBL] [Abstract][Full Text] [Related]
6. [Occupational carcinogens and mutagens in Poland - occurrence and workers' exposure in the years 2018-2021 based on the data from Central register of carcinogenic or mutagenic agents].
Klimecka A; Konieczko K; Szczęsna D; Jurewicz J
Med Pr; 2023 Dec; 74(5):399-407. PubMed ID: 38104340
[TBL] [Abstract][Full Text] [Related]
7. [Use of personal protective equipment under occupational exposure to cytostatics].
Krzemińska S; Pośniak M; Szewczyńska M
Med Pr; 2016; 67(4):499-508. PubMed ID: 27623830
[TBL] [Abstract][Full Text] [Related]
8. [Management of cytostatic drugs by nurses: analysis of preliminary results].
Bilski B
Med Pr; 2004; 55(3):243-7. PubMed ID: 15493499
[TBL] [Abstract][Full Text] [Related]
9. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
[TBL] [Abstract][Full Text] [Related]
10. [Problems concerning the integration of "derived-no-effect-levels" (DNELS) into occupational safety and health regulations].
Gromiec J
Med Pr; 2008; 59(1):65-73. PubMed ID: 18663897
[TBL] [Abstract][Full Text] [Related]
11. [Chemical carcinogenic and mutagenic agents in the workplace, Poland, 2008-2010].
Konieczko K; Pałaszewska-Tkacz A; Czerczak S
Med Pr; 2013; 64(2):181-92. PubMed ID: 23829062
[TBL] [Abstract][Full Text] [Related]
12. [Legal aspects of workers' health protection against asbestos in Poland in the light of the EU legal framework].
Swiatkowska B
Med Pr; 2013; 64(5):689-97. PubMed ID: 24502132
[TBL] [Abstract][Full Text] [Related]
13. [Rules for prevention and certification of occupational diseases in workers occupationally exposed to antineoplastic drugs].
Walusiak J; Wagrowska-Koski E; Pałczyński C
Med Pr; 2001; 52(1):39-44. PubMed ID: 11424747
[TBL] [Abstract][Full Text] [Related]
14. [Occupational exposure limits for polycyclic aromatic hydrocarbons. Current legal status and proposed changes].
Brzeźnicki S; Bonczarowska M; Gromiec JP
Med Pr; 2009; 60(3):179-85. PubMed ID: 19746885
[TBL] [Abstract][Full Text] [Related]
15. [Occupational data cards as a source of information for health prevention purposes].
Bugajska J
Med Pr; 2000; 51(6):551-61. PubMed ID: 11288683
[TBL] [Abstract][Full Text] [Related]
16. [Regulations for the protection of workers against the effects of hazardous substances at the workplace].
Wolf T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Mar; 51(3):266-73. PubMed ID: 18369561
[TBL] [Abstract][Full Text] [Related]
17. [Occupational exposure to chemical carcinogens in Poland, 2001].
Konieczko K; Czerczak S; Kluszczyński D
Med Pr; 2004; 55(1):3-6. PubMed ID: 15156760
[TBL] [Abstract][Full Text] [Related]
18. [Exposure to biological agents used in Polish enterprises: analysis of data derived from the National Register of Biological Agent].
Kozajda A; Szadkowska-Stańczyk I
Med Pr; 2011; 62(2):145-52. PubMed ID: 21698874
[TBL] [Abstract][Full Text] [Related]
19. Hygienic examination and follow-up of occupational risks of handling cytostatic drugs at an oncology unit.
Medková J
Acta Univ Palacki Olomuc Fac Med; 1991; 129():241-53. PubMed ID: 1837667
[TBL] [Abstract][Full Text] [Related]
20. [Occupational exposure to biological agents and the protection of exposed workers according to the new legal regulations].
Zielińska-Jankiewicz K; Kozajda A; Szadkowska-Stańczyk I
Med Pr; 2005; 56(4):319-23. PubMed ID: 16457370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
